Fundraising FoxBioStar Capital
Venture capitalCharlevoix · Seed–Series A · 10 people tracked
Also known as BIOSTAR MANAGERS, LLC
Find your way into BioStar Capital
Sign up to see every warm intro you have to BioStar Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioStar Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BioStar Capital focuses on transformational medical technology, combining clinical expertise with business and financial acumen. The firm brings together renowned healthcare clinicians, executives, and medical thought leaders alongside financial professionals to identify and back medical technology innovations. With more than two decades at the forefront of medtech investment, its strategy aims to produce meaningful outcomes for patients while generating strong returns for investors.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 6 of 6 portfolio companiesHealthtech ×6Medical Devices ×5Biotech ×4Advanced Manufacturing ×1Deep Tech ×1Digital Health ×1Enterprise Software ×1Robotics ×1
HQs:United States×6
Investments · 6 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12022 · 12020 · 14 dated
AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.
BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Robert Chisena, Ph.D.(Co-Founder & Chief Technology Officer)Andrew Casey(Executive Officer)inSean Gilligan(Executive Officer)inMark Toland(Executive Officer, Director)Hitinder Gurm, M.D.(Chief Clinical Officer)Robert Chisena(Executive Officer)
Board seatWilliam H. (Hank) KuchemanHank Kucheman· per SEC Form D
Co-investorsCorewell Health VenturesID Ventures
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsAndera PartnersDeerfield Management CompanyFidelity InvestmentsRA CapitalCorewell Health VenturesFountain Healthcare Partners
XLerateHealth supports healthcare innovation by providing resources and mentorship to startups in the sector, with a focus on regional development in the Midwest and Southeast.
BiotechDigital HealthEnterprise SoftwareHealthtechSector AgnosticLouisville, US
Bob Saunders(Chairman & Co-founder)inTed Smith(Co-founder)Jackie Willmot(CEO & Co-founder)Bobby Ferreri
Co-investorsChrysalis VenturesOCA VenturesRender Capital
Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.
Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US
Frank Maguire(Executive Officer, Director)
BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)
Co-investorsAngel Physicians FundKairos Venture Investments, LlcMemorialCare Innovation FundBioStar VenturesKairos Venture PartnersSUMMATION HEALTH VENTURES
Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field.
BiotechHealthtechMedical DevicesDover, US
Jack Springer(President & CEO)inBruce Roberts(Director)in
Co-investorsAlumni VenturesAphelion CapitalCorewell Health VenturesNorwest Venture Partners
Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.
HealthtechMedical DevicesSanta Cruz, US
Co-investorsCorewell Health VenturesSanta Cruz VentureView VenturesCadence Healthcare VenturesS3 Ventures
Frequently asked questions
- How many investments has BioStar Capital made?
- BioStar Capital has 6 tracked investments, including 1 dated in the last 24 months.
- What stage does BioStar Capital invest at?
- BioStar Capital invests at the Seed, Series A stages.
- What is BioStar Capital's typical check size?
- BioStar Capital typically writes checks of $250K – $3M.
- What sectors does BioStar Capital focus on?
- BioStar Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is BioStar Capital located?
- BioStar Capital is headquartered in Charlevoix, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.